Allergan Must Face Breast Implant, Class Claims In MDL

By Bill Wichert · March 19, 2021, 10:24 PM EDT

Allergan came up short Friday in its attempt to escape claims in multidistrict litigation that the company hid the cancer risks of its textured breast implants, with a New Jersey federal...

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Related Sections

Case Information

Case Title

IN RE: ALLERGAN BIOCELL TEXTURED BREAST IMPLANT PRODUCTS LIABILITY LITIGATION

Case Number

2:19-md-02921

Court

New Jersey

Nature of Suit

Personal Injury: Health Care/Pharmaceutical Personal Injury Product Liability

Date Filed

December 18, 2019